Course description

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered thoracic cancer care.

Target audience:

Medical Oncologists, Radiation Oncologists, Cardiothoracic Surgeons, Pathologists, Pulmonologists, Pharmacists, Nurses, Respiratory Therapists, Radiologic Technologists, Patient Care Facilitators and all personnel involved in the care of the lung cancer patient.

Learning objectives:

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.

•    Develop a comprehensive treatment plan for thoracic oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 

Mark Dylewski, M.D
Chief of Thoracic Surgery
Miami Cancer Institute

Paul Kaywin, M.D.
Moderator, Thoracic Tumor Board
Hematologist and Oncologist
Baptist Health South Florida

Jessica J. Eghbal, PA-C
Miami Cancer Institute

Connor J. Meehan, PA-C
Miami Cancer Institute
 

Mark Dylewski, M.D., conference director of this educational activity, has no financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Paul Kaywin, M.D., conference director of this educational activity, has no financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Jessica J. Eghbal and Connor J. Meehan, interprofessional coordinators of the educational activity, have no financial relationships with ineligible companies to disclose.

DMT coordinators others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system.